Home » Topics » Regulatory » EMA

EMA
RSS

Ebola Zaire vaccine wins FDA breakthrough therapy designation and PRIME status

July 26, 2016

EMA's CHMP adopts positive opinion on type II variation application for Gilead's Truvada

July 25, 2016

EMA committee supports approval of Eisai's Kisplyx

July 25, 2016

EMA's CHMP grants positive opinion to Cabometyx in RCC

July 25, 2016

EMA committee recommends approval of Onivyde in E.U.

July 25, 2016

EMA proposes changes to guidance on first-in-human trials

July 22, 2016

EMA grants orphan drug designation to XOMA-358

July 21, 2016

Cynapsus Therapeutics reaches agreement with the EMA for APL-130277 development

July 20, 2016

The EMA classifies AXAL as advanced therapy medicinal product

July 19, 2016

Cladribine tablet MAA accepted for review by EMA

July 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...